InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.22
(
-0.34%
)
Bitcoin
55,138.81
(
-1.27%
)

Replies to post #180 on Optimer Pharmaceuticals, Inc. (OPTR)

Replies to #180 on Optimer Pharmaceuticals, Inc. (OPTR)

kris_kade

05/19/11 11:23 AM

#181 RE: invest2win #180


$20 Target !!


Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Model Revisions Ahead of DIFICID Launch

Canaccord Genuity reiterates a 'Buy' on Optimer Pharmaceuticals (NASDAQ: OPTR), PT $20.